Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 24, 2015 11:29 AM ET

Biotechnology

Company Overview of Rosetta Genomics, Ltd.

Executive Profile

Roy N. Davis

Director and Member of Research & Development Committee, Rosetta Genomics, Ltd.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 5 different industries.

See Board Relationships
67--

Background

Mr. Roy N. Davis has been a Director of Rosetta Genomics, Ltd. since June 2012. He has been a Director of Innosight LLC since March 1, 2012. He served as a Director of Nanosphere, Inc. from October 10, 2012 to February 2013. He serves as a Member of Industrial Advisory Board at Cleveland Clinic Innovations. He served as the President of Johnson & Johnson Development Corporation since January 2008. Mr. Davis served as the Vice President of Corporate Development at Johnson ...

Corporate Headquarters

10 Plaut Street
Rehovot, -- 76706

Israel

Phone: 972 73 222 0700
Fax: 972 73 222 0701

Board Members Memberships

2012-Present
Director and Member of Research & Development Committee
2012-N/A
Former Director
2012-Present
Director

Education

BS
State University of New York
MS
Rensselaer Polytechnic Institute

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$735.3K
Kimberly J. Popovits Chairman, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$660.0K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$767.9K
Bonnie H. Anderson Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee
Veracyte, Inc.
$425.0K
Michael J. Pellini M.D., MBAChief Executive Officer and Director
Foundation Medicine, Inc.
$416.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Rosetta Genomics, Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.